test Browse by Author Names Browse by Titles of Works Browse by Subjects of Works Browse by Issue Dates of Works

Advanced Search
& Collections
Issue Date   
Sign on to:   
Receive email
My Account
authorized users
Edit Profile   
About T-Space   

T-Space at The University of Toronto Libraries >
University of Toronto at Scarborough >
Bioline International Legacy Collection >
Bioline International Legacy Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1807/5324

Title: Isolated testicular relapse in acute lymphoblastic leukemia - effective treatment with the modified CCG-112 protocol
Authors: Goyal, Shama
Bhagwat, Roshni
Pai, Suresh K.
Kurkure, Purna A.
Nair, Chandrika N.
Parikh, Purvish M.
Mukaden, Maryann A.
Banavali, Shripad D.
Keywords: Childhood acute lymhoblastic leukemia, Modified CCG protocol, Isolated testicular relapse
Issue Date: 31-Dec-2005
Publisher: Medknow Publications on behalf of Indian Cancer Society
Citation: Indian Journal of Cancer (ISSN: 0019-509X) Vol 42 Num 2
Abstract: BACKGROUND: The testes have been considered a sanctuary site for leukemic cells and testicular relapses used to account for a major proportion of the poor outcome of boys with acute lymphoblastic leukemia. With use of aggressive chemotherapy which includes intermediate or high dose methotrexate, the incidence of testicular relapses has declined. However once these patients have received cranial irradiation as a part of the front line protocol, high dose methotrexate needs to be avoided because of risk of developing leucoencephalopathy. AIM: To study the use of non cross resistant chemotherapeutic agents along with a regimen containing lower doses of methotrexate in patients of isolated testicular relapse (ITR). MATERIALS AND METHODS: This is a retrospective analysis of 12 consecutive patients with ITR treated with modified version of the CCG-112 protocol which consists of intensive systemic chemotherapy, cranial chemoprophylaxis along with testicular irradiation. RESULTS: One patient died of regimen related toxicity. Two patients relapsed in the bone marrow during maintenance. Of the nine patients who completed treatment, eight are alive and in remission. One patient had a bone marrow relapse two months after completing treatment. The Kaplan Meier estimates give us an Event Free Survival (EFS) of 66.7% at 10 yrs. CONCLUSIONS: Thus, though the incidence is very low, patients with ITR should be treated aggressively since they have an excellent chance of achieving a long term EFS.
URI: http://hdl.handle.net/1807/5324
Other Identifiers: http://www.bioline.org.br/abstract?id=cn05013
Rights: Copyright 2005 Indian Journal of Cancer.
Appears in Collections:Bioline International Legacy Collection

Files in This Item:

File Description SizeFormat
cn05013.pdf81.99 kBAdobe PDF

Items in T-Space are protected by copyright, with all rights reserved, unless otherwise indicated.